Thursday, December 12, 2019
Home Healthcare

Healthcare

Impact focus – Solutions that remimagine access and affordability of healthcare

Medicare may not be getting the best prescription drug deals it can, meaning senior citizens using the plan are overpaying, a new study suggests. Private insurance companies adopt cheaper generic drugs at a faster...
Good ultrasound images of the heart can be especially elusive; the heart is a perpetually moving target, tucked behind the thick walls of the chest. San Francisco-based startup Caption Health is aiming to make heart sonograms more...
This content is brought to you in partnership with HLTH. How do we create the future of health? That’s the question HLTH is seeking to answer.  From Oct. 27-30, more than...
A handful of biotech companies are pursuing the development of microbiome drugs, and many prominent investors are placing their bets. With $35 million series B funding led by Sequoia Capital, Whole Biome is on track...
On Our Radar: Deals we are paying attention to for their impact on industry. Biotech firm Cullgen’s April 10 announcement that it had received a $16 million Series A financing aimed at advancing treatment of cancer and inflammatory and autoimmune...
This content is brought to you in partnership with HLTH. Last week, more than 6,000 attendees — from executives, investors and startups to policymakers, pharmaceutical companies and insurance providers — gathered at the MGM...
Amazon and JPMorgan Chase, working with Warren Buffett’s Berkshire Hathaway, are rolling out employee healthcare plans, the latest example of big tech making unlikely alliances in an effort to carve out territory in healthcare.
The number of Americans without health insurance rose by 1.9 million last year, the first increase since the Affordable Care Act took effect in 2013, after the Trump Administration weakened efforts to enroll more people.Uninsured residents totaled...
OnSite Waste Technologies says the high costs and inefficiencies of medical waste disposal services makes the industry ripe for disruption. Just earlier this month, the Newport Beach, California-based OnSite closed a $3.5 million seed funding round, led...
Xbiome, which calls itself China’s first AI-based company that specializes in the development of gut microbiome, has raised a total of about $10 million in two venture funding rounds as investors pour money into firms developing products...
KKR, which last month said profit slipped on costlier dealmaking, proposed buying Walgreens Boots Alliance as the private equity firm pushes deeper into healthcare.  The potential deal, reported by Bloomberg News based on unidentified...
Climate change has become an “irreversible” health crisis in Australia with dire consequences for the Asia-Pacific nation, including an increase in potentially lethal mosquito-borne tropical diseases like malaria and dengue fever, Australian doctors say.The bleak assessment by...
India’s booming online insurance market is drawing more investors, attracted by the subcontinent’s vast population, opening insurance market and widening middle class. The latest sign of the burgeoning market: the $18.9 million funding round for RenewBuy, a...
Europe is looking to revolutionize healthcare with a massive project that would  make millions of patient records available to artificial intelligence algorithms. The multi-billion-dollar European Health Data and Evidence Network project will standardize 100...
Sound Businesses: Companies we are keeping an eye on. Sathya Elumalai is the CEO of Aidar Health, a digital healthcare company that provides monitoring of health data, cloud-based machine learning and other proprietary technology applications. Improving patient care globally has been the...
Germany’s Vasopharm raised $10.7 million as it plans to submit data for a clinical trial next year for its product that seeks to treat an issue with far-reaching social implications: traumatic brain injury.  Led...
Pacemakers, insulin pumps and other medical devices using software called IPnet contain potential flaws that make them vulnerable to cyber attacks, the Food and Drug Administration has warned.The agency is working with medical device makers to determine...
While the number of microbiome-focused products and investments rises, the science remains in a nascent stage, and expectations for the industry may be ahead of reality, according to speakers at a Bard College symposium on Thursday.
Life sciences start-up MEND believes better nutrition will help concussion patients before and after surgery, and is seeking to roll out another of its supplement powders to tap that market. The New York company...
Many children have been learning their ABCs through video games. Now Mightier wants to help them conquer anxiety and depression disorders using the same technology.  The gaming startup seeks to treat children with ADHD...
Surging popularity of home DNA kits that enable consumers to uncover secrets of their ancestry and health risks has fueled speculation that the industry is set for further disruption this year. Ancestry.com, the world’s largest direct-to-consumer genetic-testing company, is getting...
Key Takeaway: The world’s biggest tech firms, including Alphabet, Amazon and Apple, are using cutting edge digital technologies to build the future of healthcare, a more than...
Sound Businesses: Profiles of companies and business models we are keeping an eye on. Diagnostic-imaging company Zebra Medical Vision combines the knowledge of images and the power of the cloud to read X-Ray,...
Magnetar Capital, which has made billions on its energy and infrastructure bets, is joining others who are seeing green lights flashing in healthcare. The $13.4 billion hedge fund is seeking to raise $400 million,...
A lawsuit filed by the Trump administration against Gilead Sciences is the most direct action taken to date to bring down the high cost of HIV prevention pills – a critical component of the government’s plan to...
German start-up BioNTech raised $325 million in private funding, one of the largest hauls for a European biopharma company, which will help it develop its pipeline for cancer therapies designed to target unique characteristics of each patient’s...
Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see. Just two drops of blood is all it takes — that is Sight Diagnostics’ promise to analyze, in a matter of seconds,...
On Our Radar: Deals we are paying attention to, for their impact on industry. It was a good day for artificial intelligence companies in the healthcare space. A very good day. Within hours on Wednesday, three firms developing AI-based platforms, PathAI, Bardy...
Google says it wants to be more than just a search engine for breast-cancer patients -- a point  CFO Ruth Porat makes in a blog post in which she discusses her own struggles with the disease.
In a move certain to set medical ethicists’ heads spinning, stem-cell researchers in Japan are launching a study with an aim to create hybrid animals out of rats and mice that will produce human organs for medical...
- Advertisement -